Urachal adenocarcinoma: a rare bladder tumor management
https://doi.org/10.17650/1726-9776-2024-20-2-129-133
Abstract
Urachal adenocarcinoma is a rare and aggressive form of non-urothelial carcinoma. It commonly encountered the bladder at the dome or along its midline. Adenocarcinoma histology with frequent mucinous or signet ring cell features distinguishes it from traditional urothelial tumours. It usually manifests in adults aged 47 to 56, with an even distribution between genders. It constitutes about 0.5 to 2 % of all bladder malignancies. Surgery remains the primary treatment modality in prolonging patients’ overall survival time. We wish to discuss a case of a patient diagnosed with urachal adenocarcinoma.
About the Authors
M. Pannirselvam
Universiti Sains Malaysia
Malaysia
Malaysia
Department of Surgery, School of Medical Sciences, Universti Sains Malaysia
Kubang Kerian, Kelantan, Malaysia
M. A. M. Daud
Universiti Sains Malaysia;
Hospital Universiti Sains Malaysia
Malaysia
Malaysia
Hospital Universiti Sains Malaysia; Urology Unit, Department of Surgery, School of Medical Sciences, Universiti Sains Malaysia
Kubang Kerian, Kelantan, Malaysia
M. F. Othman
Universiti Sains Malaysia;
Hospital Universiti Sains Malaysia
Malaysia
Malaysia
Muhammad Faeid Othman
Hospital Universiti Sains Malaysia; Urology Unit, Department of Surgery, School of Medical Sciences, Universiti Sains Malaysia
Kubang Kerian, Kelantan, Malaysia
A. F. N. M. Ghazi
Universiti Sains Malaysia;
Hospital Universiti Sains Malaysia
Malaysia
Malaysia
Hospital Universiti Sains Malaysia; Urology Unit, Department of Surgery, School of Medical Sciences, Universiti Sains Malaysia
Kubang Kerian, Kelantan, Malaysia
S. S. Tan
Universiti Sains Malaysia
Malaysia
Malaysia
Department of Surgery, School of Medical Sciences, Universiti Sains Malaysia
Kubang Kerian, Kelantan, Malaysia
G. C. Teh
Sarawak General Hospital
Malaysia
Malaysia
Department of Urology
Kuching, Sarawak, Malaysia
References
1. Begg R.C. The urachus: its anatomy, histology and development. J Anat 1930;64(Pt 2):170–83.
2. Scabini S., Rimini E., Romairone E. et al. Urachal tumour: case report of a poorly understood carcinoma. World J Surg Oncol [Internet] 2009 [cited 2023];7(1):1–3. Available at: https://wjso.biomedcentral.com/articles/10.1186/1477-7819-7-82
3. Schubert G.E., Pavkovic M.B., Bethke-Bedurftig B.A. Tubular urachal remnants in adult bladders. J Urol 1982;127(1):40–2. DOI: 10.1016/s0022-5347(17)53595-8
4. Sheldon C.A., Clayman R.V., Gonzalez R. et al. Malignant urachal lesions. J Urol 1984;131(1):1–8. DOI: 10.1016/s0022-5347(17)50167-6
5. Pinthus J.H., Haddad R., Trachtenberg J. et al. Population based survival data on urachal tumors. J Urol 2006;175(6):2042–7. DOI: 10.1016/S0022-5347(06)00263-1
6. Ghazizadeh M., Yamamoto S., Kurokawa K. Clinical features of urachal carcinoma in Japan: review of 157 patients. Urol Res 1983;11(5):235–8. DOI: 10.1007/BF00272286
7. Siefker-Radtke A.O., Gee J., Shen Y. et al. Multimodality management of urachal carcinoma: the M.D. Anderson Cancer Center experience. J Urol 2003;169(4):1295–8. DOI: 10.1097/01.ju.0000054646.49381.01
8. Molina J.R., Quevedo J.F., Furth A.F. et al. Predictors of survival from urachal cancer. Cancer 2007;110(11):2434–40. DOI: 10.1002/cncr.23070
9. Ashley R.A., Inman B.A., Sebo T.J. et al. Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy. Cancer 2006;107(4):712–20. DOI: 10.1002/cncr.22060
10. Siefker-Radtke A. Urachal carcinoma: surgical and chemotherapeutic options. Expert Rev Anticancer Ther 2014;6(12):1715–21. DOI: 10.1586/14737140.6.12.1715
11. Wong-You-Cheong J.J., Woodward P.J., Manning M.A., Sesterhenn I.A. Neoplasms of the urinary bladder: radiologicpathologic correlation. Radiographics 2006;26(2):553–80. DOI: 10.1148/rg.262055172
12. Gopalan A., Sharp D.S., Fine S.W. et al. Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation. Am J Surg Pathol 2009;33(5):659–68. DOI: 10.1097/PAS.0b013e31819aa4ae
13. Singh I., Prasad R. Primary urachal mucinous adenocarcinoma of the urinary bladder. J Clin Diagn Res 2013;7(5):911–3. DOI: 10.7860/JCDR/2013/5597.2973
14. Henly D.R., Farrow G.M., Zincke H. Urachal cancer: role of conservative surgery. Urology 1993;42(6):635–9. DOI: 10.1016/0090-4295(93)90526-g
15. Herr H.W., Bochner B.H., Sharp D. et al. Urachal carcinoma: contemporary surgical outcomes. J Urol 2007;178(1):74–8. DOI: 10.1016/j.juro.2007.03.022
16. Elser C., Sweet J., Cheran S.K. et al. A case of metastatic urachal adenocarcinoma treated with several different chemotherapeutic regimens. Can Urol Assoc J 2012;6(1):E27–31. DOI: 10.5489/cuaj.11109
Review
For citations:
Pannirselvam M., Daud M., Othman M.F., Ghazi A., Tan S.S., Teh G.C. Urachal adenocarcinoma: a rare bladder tumor management. Cancer Urology. 2024;20(2):129-133. https://doi.org/10.17650/1726-9776-2024-20-2-129-133
Views:
477
Email this article 